Overview

Randomized, Double Blind, Multicenter Study of the Safety and Efficacy of Valdecoxib 40 mg Once Daily Compared With Diclofenac 75 mg Twice Daily in Acute Low Back Pain

Status:
Completed

Trial end date:
2003-05-01

Target enrollment:

Participant gender:

Summary

The pain relief, safety, and tolerability of valdecoxib 40 mg once daily compared with diclofenac 75 mg twice daily for acute low back pain was studied. The effect of valdecoxib on the patient's level of disability and quality of life was also studied.

Phase:

Phase 4

Details

Lead Sponsor:

Pfizer

Treatments:

Diclofenac
Valdecoxib